DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMLAMSRAGP

Candidal intertrigo

Essential points for quick revision.

Synopsis

Recognise Candida-associated fold inflammation, distinguish it from dermatophyte, bacterial and inflammatory mimics, correct moisture and friction, and use topical antifungal treatment while investigating recurrent disease selectively.

  • Candidal intertrigo is a sore, moist, confluent fold eruption with maceration, fissures and possible satellite papules or pustules.
  • Erythema may look red, violet, grey or dark brown across skin tones; gloss, erosion, tenderness and satellite morphology are often more reliable.
  • Reduce moisture and friction with gentle drying, breathable clothing, absorbent non-adherent material and management of sweat or incontinence.

Key red flags

Fever, rapidly spreading pain, crepitus, necrosis, perineal involvement, diabetic decompensation, severe immune compromise, extensive erosion or failure of a well-used regimen requires urgent or specialist reassessment.

Invasive-infection departure

Rapid spread, disproportionate pain, crepitus, necrosis, fever or shock is not uncomplicated intertrigo and needs emergency care.

Investigation priorities

01
Skin scraping or fungal swabFirst step

Confirm Candida or dermatophyte in recurrent, atypical or non-responsive disease.

Management branches

Typical uncomplicated diseaseDry and treat the fold

A local moist satellite-pustular fold eruption occurs without invasive infection or major immune compromise.

  1. Clean gently, pat completely dry, reduce friction and moisture and address incontinence or occlusive clothing.
  2. Apply clotrimazole 1% cream thinly two or three times daily for at least two weeks, extending to the affected margin.

Key medicines

Clotrimazole 1% creamApply a thin layer two or three times daily to clean dry affected folds for at least two weeks according to response and product information.
Open full textbook Answer 2 questions
Sources and review status3 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom